Taconic Capital Advisors L.P. said on Friday it has accumulated a 7.46 percent stake in Cephalon Inc (CEPH.O), subject of a $5.7 billion bid from Valeant Pharmaceuticals (VRX.TO). Taconic said the position was built for investment purposes and not with a view towards changing or influencing control of Cephalon.
Source
